FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384153342> ?p ?o ?g. }

• W4384153342 abstract "Abstract Background : The primary and secondary resistance of luminal breast cancer (LBC) against endocrine therapy is a serious clinical problem. At present, it has been confirmed that Erxian Decoction can improve the sensitivity of LBC to tamoxifen (TAM), but its mechanism is not clear. The purpose of this paper is to explore the molecular mechanism that causes Erxian Decoction to increase the sensitivity of LBC to TAM. Methods : The potential targets and related pathways of Erxian Decoction inhibiting LBC were screened through bioinformatics. The small molecular compounds that could stably bind to LBC targets were determined by molecular docking. The stable interaction of the target and the small molecular compounds was revealed by the cell thermal shift assay (CETSA). Cell Counting Kit‐8 (CCK‐8) was used to verify the effect of Erxian Decoction and TAM on the cell activity of LBC. Flow cytometry was used to verify the effect of Erxian Decoction and TAM on the apoptosis of LBC cells. Western blot was used to detect the expression of PI3K‐AKT pathway‐related proteins in cells. Results : ERBB2 was screened as a potential target for the treatment of LBC. Based on molecular docking and CETSA results, the stable interaction between luteolin and ERBB2 was confirmed. CCK‐8 results showed that luteolin could inhibit the cell activity of LBC, and luteolin treatment could improve the drug sensitivity of tumor cells to TAM. The results of flow cytometry showed that compared with TAM treatment alone, the addition of luteolin trefatment promoted the apoptosis level of LBC cells. Western blot results indicated that luteolin could inhibit the PI3K‐AKT signal pathway by combining with ERBB2. Conclusion : Luteolin in Erxian Decoction inhibited the progression of LBC and enhanced the sensitivity of LBC to TAM by binding with ERBB2 to down‐regulate the activity of the PI3K‐AKT signaling pathway. This study provided theoretical support for endocrine therapy of TAM‐resistant LBC patients." @default.
• W4384153342 created "2023-07-14" @default.
• W4384153342 creator A5001556956 @default.
• W4384153342 creator A5004483141 @default.
• W4384153342 creator A5013769680 @default.
• W4384153342 creator A5029361680 @default.
• W4384153342 creator A5029665853 @default.
• W4384153342 creator A5064604073 @default.
• W4384153342 date "2023-07-13" @default.
• W4384153342 modified "2023-09-25" @default.
• W4384153342 title "Erxian Decoction Enhances the Tamoxifen Sensitivity in Luminal Breast Cancer through the PI3K‐AKT Signaling Pathway" @default.
• W4384153342 cites W1964321121 @default.
• W4384153342 cites W2035618305 @default.
• W4384153342 cites W2037266556 @default.
• W4384153342 cites W2078585577 @default.
• W4384153342 cites W2146512944 @default.
• W4384153342 cites W2159675211 @default.
• W4384153342 cites W2745064318 @default.
• W4384153342 cites W2767600184 @default.
• W4384153342 cites W2803578968 @default.
• W4384153342 cites W2900863907 @default.
• W4384153342 cites W2913520640 @default.
• W4384153342 cites W2917968580 @default.
• W4384153342 cites W2949079733 @default.
• W4384153342 cites W2951923105 @default.
• W4384153342 cites W2967762032 @default.
• W4384153342 cites W2985055874 @default.
• W4384153342 cites W3003597907 @default.
• W4384153342 cites W3014145691 @default.
• W4384153342 cites W3023654020 @default.
• W4384153342 cites W3027384030 @default.
• W4384153342 cites W3043709999 @default.
• W4384153342 cites W3110957220 @default.
• W4384153342 cites W3160382664 @default.
• W4384153342 cites W3177423319 @default.
• W4384153342 cites W3184387274 @default.
• W4384153342 cites W3209728966 @default.
• W4384153342 cites W4200584507 @default.
• W4384153342 cites W4210568616 @default.
• W4384153342 cites W4224316909 @default.
• W4384153342 doi "https://doi.org/10.1002/slct.202300700" @default.
• W4384153342 hasPublicationYear "2023" @default.
• W4384153342 type Work @default.
• W4384153342 citedByCount "0" @default.
• W4384153342 crossrefType "journal-article" @default.
• W4384153342 hasAuthorship W4384153342A5001556956 @default.
• W4384153342 hasAuthorship W4384153342A5004483141 @default.
• W4384153342 hasAuthorship W4384153342A5013769680 @default.
• W4384153342 hasAuthorship W4384153342A5029361680 @default.
• W4384153342 hasAuthorship W4384153342A5029665853 @default.
• W4384153342 hasAuthorship W4384153342A5064604073 @default.
• W4384153342 hasConcept C104317684 @default.
• W4384153342 hasConcept C1491633281 @default.
• W4384153342 hasConcept C185592680 @default.
• W4384153342 hasConcept C190283241 @default.
• W4384153342 hasConcept C190409667 @default.
• W4384153342 hasConcept C203014093 @default.
• W4384153342 hasConcept C2776080593 @default.
• W4384153342 hasConcept C2776415932 @default.
• W4384153342 hasConcept C2778004101 @default.
• W4384153342 hasConcept C2779054382 @default.
• W4384153342 hasConcept C502942594 @default.
• W4384153342 hasConcept C553184892 @default.
• W4384153342 hasConcept C55493867 @default.
• W4384153342 hasConcept C556039675 @default.
• W4384153342 hasConcept C62112901 @default.
• W4384153342 hasConcept C71924100 @default.
• W4384153342 hasConcept C75217442 @default.
• W4384153342 hasConcept C86554907 @default.
• W4384153342 hasConcept C98274493 @default.
• W4384153342 hasConceptScore W4384153342C104317684 @default.
• W4384153342 hasConceptScore W4384153342C1491633281 @default.
• W4384153342 hasConceptScore W4384153342C185592680 @default.
• W4384153342 hasConceptScore W4384153342C190283241 @default.
• W4384153342 hasConceptScore W4384153342C190409667 @default.
• W4384153342 hasConceptScore W4384153342C203014093 @default.
• W4384153342 hasConceptScore W4384153342C2776080593 @default.
• W4384153342 hasConceptScore W4384153342C2776415932 @default.
• W4384153342 hasConceptScore W4384153342C2778004101 @default.
• W4384153342 hasConceptScore W4384153342C2779054382 @default.
• W4384153342 hasConceptScore W4384153342C502942594 @default.
• W4384153342 hasConceptScore W4384153342C553184892 @default.
• W4384153342 hasConceptScore W4384153342C55493867 @default.
• W4384153342 hasConceptScore W4384153342C556039675 @default.
• W4384153342 hasConceptScore W4384153342C62112901 @default.
• W4384153342 hasConceptScore W4384153342C71924100 @default.
• W4384153342 hasConceptScore W4384153342C75217442 @default.
• W4384153342 hasConceptScore W4384153342C86554907 @default.
• W4384153342 hasConceptScore W4384153342C98274493 @default.
• W4384153342 hasIssue "26" @default.
• W4384153342 hasLocation W43841533421 @default.
• W4384153342 hasOpenAccess W4384153342 @default.
• W4384153342 hasPrimaryLocation W43841533421 @default.
• W4384153342 hasRelatedWork W1613572233 @default.
• W4384153342 hasRelatedWork W2350294409 @default.
• W4384153342 hasRelatedWork W2354128257 @default.
• W4384153342 hasRelatedWork W2354735832 @default.
• W4384153342 hasRelatedWork W2369710241 @default.
• W4384153342 hasRelatedWork W2371611592 @default.
• W4384153342 hasRelatedWork W2382230817 @default.

• next